Loading company…
Zhejiang Zhengxi Bio-Technology develops monoclonal antibodies, research reagents and medical testing services.
Founded in 2017 and based in Huzhou, Zhejiang Zhengxi Bio-Technology develops monoclonal antibodies and reagents for research and diagnostic testing. Its products support flow cytometry, immunohistochemistry and multi-omics, and it also provides medical inspection services. The company closed a strategic investment in November 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in